Looking Into HOOKIPA Pharma's Return On Capital Employed

By: via Benzinga
According to data from Benzinga Pro, during Q4, HOOKIPA Pharma's (NASDAQ:HOOK) reported sales totaled $7.83 million. Despite a 32.65% ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.